O-glycosylation regulates LNCaP prostate cancer cell susceptibility to apoptosis induced by galectin-1
- PMID: 17616672
- DOI: 10.1158/0008-5472.CAN-05-4431
O-glycosylation regulates LNCaP prostate cancer cell susceptibility to apoptosis induced by galectin-1
Abstract
Resistance to apoptosis is a critical feature of neoplastic cells. Galectin-1 is an endogenous carbohydrate-binding protein that induces death of leukemia and lymphoma cells, breast cancer cells, and the LNCaP prostate cancer cell line, but not other prostate cancer cell lines. To understand the mechanism of galectin-1 sensitivity of LNCaP cells compared with other prostate cancer cells, we characterized glycan ligands that are important for conferring galectin-1 sensitivity in these cells, and analyzed expression of glycosyltransferase genes in galectin-1-sensitive, prostate-specific antigen-positive (PSA(+)) LNCaP cells compared with a galectin-1-resistant PSA(-) LNCaP subclone. We identified one glycosyltransferase, core 2 N-acetylglucosaminyltransferase, which is down-regulated in galectin-1-resistant PSA(-) LNCaP cells compared with galectin-1-sensitive PSA(+) LNCaP cells. Intriguingly, this is the same glycosyltransferase required for galectin-1 susceptibility of T lymphoma cells, indicating that similar O-glycan ligands on different polypeptide backbones may be common death trigger receptors recognized by galectin-1 on different types of cancer cells. Blocking O-glycan elongation by expressing alpha2,3-sialyltransferase 1 rendered LNCaP cells resistant to galectin-1, showing that specific O-glycans are critical for galectin-1 susceptibility. Loss of galectin-1 susceptibility and synthesis of endogenous galectin-1 has been proposed to promote tumor evasion of immune attack; we found that galectin-1-expressing prostate cancer cells killed bound T cells, whereas LNCaP cells that do not express galectin-1 did not kill T cells. Resistance to galectin-1-induced apoptosis may directly contribute to the survival of prostate cancer cells as well as promote immune evasion by the tumor.
Similar articles
-
Galectin-1-mediated apoptosis in mycosis fungoides: the roles of CD7 and cell surface glycosylation.Mod Pathol. 2003 Jun;16(6):543-51. doi: 10.1097/01.MP.0000071840.84469.06. Mod Pathol. 2003. PMID: 12808059
-
Tumor suppressor p16INK4a--modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells.FEBS J. 2007 Jul;274(13):3233-56. doi: 10.1111/j.1742-4658.2007.05851.x. Epub 2007 May 29. FEBS J. 2007. PMID: 17535296
-
Expression of core 2 beta1,6-N-acetylglucosaminyltransferase facilitates prostate cancer progression.Glycobiology. 2005 Oct;15(10):1016-24. doi: 10.1093/glycob/cwi086. Epub 2005 Jun 2. Glycobiology. 2005. PMID: 15932919
-
On the role of galectin-3 in cancer apoptosis.Apoptosis. 2005 Mar;10(2):267-75. doi: 10.1007/s10495-005-0801-y. Apoptosis. 2005. PMID: 15843888 Review.
-
PSA-based vaccines for the treatment of prostate cancer.Expert Rev Vaccines. 2006 Apr;5(2):199-209. doi: 10.1586/14760584.5.2.199. Expert Rev Vaccines. 2006. PMID: 16608420 Review.
Cited by
-
Galectin-Binding O-Glycosylations as Regulators of Malignancy.Cancer Res. 2015 Aug 15;75(16):3195-202. doi: 10.1158/0008-5472.CAN-15-0834. Epub 2015 Jul 29. Cancer Res. 2015. PMID: 26224120 Free PMC article. Review.
-
The emerging role of galectins in (re)myelination and its potential for developing new approaches to treat multiple sclerosis.Cell Mol Life Sci. 2020 Apr;77(7):1289-1317. doi: 10.1007/s00018-019-03327-7. Epub 2019 Oct 18. Cell Mol Life Sci. 2020. PMID: 31628495 Free PMC article. Review.
-
The Foxp3+ regulatory T cell: a jack of all trades, master of regulation.Nat Immunol. 2008 Mar;9(3):239-44. doi: 10.1038/ni1572. Nat Immunol. 2008. PMID: 18285775 Free PMC article. Review.
-
Lectins: getting familiar with translators of the sugar code.Molecules. 2015 Jan 22;20(2):1788-823. doi: 10.3390/molecules20021788. Molecules. 2015. PMID: 25621423 Free PMC article. Review.
-
Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation.Nat Rev Immunol. 2009 May;9(5):338-52. doi: 10.1038/nri2536. Nat Rev Immunol. 2009. PMID: 19365409 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous